Article Details
Retrieved on: 2020-12-01 23:19:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company will use the funds from the sale as working capital to fund its core strategy to be a fully vertically integrated, <b>biopharma</b> company.
Article found on: www.proactiveinvestors.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here